![](/img/cover-not-exists.png)
Tumor Cells Chronically Treated with a Trastuzumab-Maytansinoid Antibody-Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments
Loganzo, F., Tan, X., Sung, M., Jin, G., Myers, J. S., Melamud, E., Wang, F., Diesl, V., Follettie, M. T., Musto, S., Lam, M.-H., Hu, W., Charati, M. B., Khandke, K., Kim, K. S. K., Cinque, M., Lucas,Volume:
14
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-14-0862
Date:
April, 2015
File:
PDF, 998 KB
english, 2015